wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Kintsugi

Total questions: 14

Worksheet time: 10mins

Name
Class
Date
1.

Name

4 lines
2.

Trastuzumab is a ________ type of monoclonal antibody.

a)

Murine

b)

Chimeric

c)

Humanized

d)

Fully recombinant

3.

Hermab is a brand from which company?

a)

RPG

b)

Glenmark

c)

Roche

d)

Biocon

4.

Which of the following is a target for Trastuzumab?

a)

BRCA

b)

KIT

c)

HER2

d)

HR

5.

Which of the following is NOT the indication for Trastuzumab?

a)

MBC

b)

Adjuvant breast cancer

c)

Lung cancer

d)

Metastatic gastric cancer

6.

Trastuzumab in Kintsugi, is available in which of the following strengths/SKUs?

a)

Lyophilised formulation 450mg and 150mg

b)

Lyophilised formulation 440mg and 150mg

c)

Liquid formulation 450mg and 150mg

d)

Tablet formulation 440mg and 150mg

7.

Trastuzumab controls tumor growth by _____________. More than one correct answer.

a)

Activating ADCC

b)

Inhibit cell proliferation

c)

All of the above

d)

Prevent angiogenesis

8.

Which of the following drugs can be given in combination with trastuzumab in treatment of MBC? More than one correct answer.

a)

Both

b)

Doxorubicin

c)

Cyclophosphamide

d)

None of the mentioned

9.

Dose of trastuzumab in breast cancer is ________.

a)

4mg/kg initially with 2mg/kg maintenance once weekly

b)

6mg/kg initially with 4mg/kg maintenance once weekly

c)

8mg/kg initially with 4mg/kg maintenance once weekly

d)

2mg/kg initially with 4mg/kg maintenance once weekly

10.

Trastuzumab is indicated for patients with breast cancer who test positive for which biomarker?

a)

Estrogen receptor (ER)

b)

Progesterone receptor (PR)

c)

HER2/neu receptor

d)

all of the above

11.

How is Trastuzumab typically administered?

a)

Orally

b)

Intramuscularly

c)

Subcutaneously

d)

Intravenously

12.

__________is the time between randomization / start of treatment and an event- leading to hospitalization (Disease progression, Treatment discontinuation, Death, Relapse).

a)

DFS

b)

ORR

c)

PCR

d)

EFS

13.

Which of the following trial suggest use of trastuzumab in EBC? More than one correct answer

a)

HERA

b)

NOAH

c)

M77001

d)

BCIRG

14.

Therapies that work on specific protein, receptor or hormone are called as ___________

a)

Cytotoxic drugs

b)

Hormonal therapies

c)

Targeted therapies

d)

Adjuvant therapies